- Home
- KOSS vs CNTB Comparison
KOSS vs CNTB Comparison
Compare KOSS & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- CNTB
- Stock Information
- Founded
- KOSS 1953
- CNTB 2012
- Country
- KOSS United States
- CNTB United States
- Employees
- KOSS N/A
- CNTB N/A
- Industry
- KOSS Consumer Electronics/Appliances
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- CNTB Health Care
- Exchange
- KOSS Nasdaq
- CNTB Nasdaq
- Market Cap
- KOSS 49.1M
- CNTB 94.2M
- IPO Year
- KOSS N/A
- CNTB 2021
- Fundamental
- Price
- KOSS $4.83
- CNTB $1.71
- Analyst Decision
- KOSS
- CNTB Strong Buy
- Analyst Count
- KOSS 0
- CNTB 3
- Target Price
- KOSS N/A
- CNTB $8.33
- AVG Volume (30 Days)
- KOSS 57.5K
- CNTB 78.5K
- Earning Date
- KOSS 10-30-2025
- CNTB 11-30-2025
- Dividend Yield
- KOSS N/A
- CNTB N/A
- EPS Growth
- KOSS N/A
- CNTB N/A
- EPS
- KOSS N/A
- CNTB N/A
- Revenue
- KOSS $13,493,080.00
- CNTB $1,965,000.00
- Revenue This Year
- KOSS N/A
- CNTB N/A
- Revenue Next Year
- KOSS N/A
- CNTB $453,067.90
- P/E Ratio
- KOSS N/A
- CNTB N/A
- Revenue Growth
- KOSS 11.58
- CNTB N/A
- 52 Week Low
- KOSS $4.00
- CNTB $1.23
- 52 Week High
- KOSS $8.59
- CNTB $2.20
- Technical
- Relative Strength Index (RSI)
- KOSS 41.40
- CNTB 51.92
- Support Level
- KOSS $4.75
- CNTB $1.46
- Resistance Level
- KOSS $5.30
- CNTB $1.72
- Average True Range (ATR)
- KOSS 0.32
- CNTB 0.14
- MACD
- KOSS -0.00
- CNTB -0.01
- Stochastic Oscillator
- KOSS 11.22
- CNTB 56.82
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.